Horiba for Healthcare

17/09/2026

Meet HORIBA at COLABIOCLI XXVII 2026 in Santa Cruz de la Sierra, Bolivia!
Join us October 7-10 and visit our partner DIAMEDIC at Booth #27 to discover the latest innovations in hematology and hemostasis, including the Yumizen H500 hematology analyzer and the Yumizen G405 hemostasis analyzer.

Don't miss our exclusive HORIBA workshops on October 9:
🔹 Coagulation Workshop: The Clinical Value and Biological Variability of D-Dimer Assays, Presented by Bruno Pougault, HORIBA ABX SAS
🔹 Hematology Workshop: Clinical Performance of Immature Leukocytes and Blasts from Extended Leukocyte Differential Counts and System Flags on HORIBA Yumizen H2500, Presented by Pascal Berthet, HORIBA ABX SAS

Whether you're a laboratory technician, laboratory manager, clinician, distributor, or interested in becoming a HORIBA distribution partner in Latin America, this is a great opportunity to connect with our team, explore our solutions, and discuss future collaborations.

We look forward to meeting you in Bolivia!

Congress registration: https://eu1.hubs.ly/H0ymmSb0

16/09/2026

🔬 New Chase the Case #60: Chronic Myeloid Leukemia (CML)

In this month's Chase the Case, explore a clinical case of Chronic Myeloid Leukemia (CML) and review the analyzer patterns, blood smear findings, and key observations that contributed to the diagnosis.

✅ View the case on the website: https://eu1.hubs.ly/H0ym6jN0
✅ Subscribe: https://eu1.hubs.ly/H0ym6kH0

10/09/2026

2,500 tests per day across hematology, clinical chemistry, immunology, bacteriology, and PCR. That is the daily reality at Cito Medical Center in Tbilisi, Georgia, a facility that has upheld international quality standards since 1997.

When hemostasis workload outgrew their semi-automated system, Dr. Salome Akhvelediani, Head of Laboratory, transitioned to the Yumizen G800 to improve workflow, simplify operation, and deliver more accurate, reliable results with full automation.

Their quality protocol is rigorous. At Cito Medical Center, they recalculate local MNPT at every reagent lot change, measuring PT across 30 healthy individuals. That level of quality management helps ensure reliable PT/INR results.

▶️ Watch Dr. Akhvelediani share how the Yumizen G800 fits into her laboratory's daily workflow and what she expects next from hemostasis technology.

02/09/2026

As we continue to strengthen our commitment to diagnostics, we are proud to recognize the experts whose passion, knowledge, and dedication help advance animal health every day.

Today, we spotlight Lisa Martin, who leads the Veterinary business at HORIBA UK. Driven by a lifelong passion for animal welfare, Lisa has built her career around supporting veterinary professionals with solutions that enable faster, more reliable diagnostic insights and better outcomes for their patients.

Beyond her role, Lisa is committed to sharing knowledge and fostering the next generation of scientists through education, training initiatives, and STEM outreach activities.

As HORIBA expands its veterinary portfolio with new innovations and solutions, passionate experts like Lisa demonstrate the expertise and enthusiasm that continue to drive our mission forward.

🔗Read Lisa's inspiring story: https://eu1.hubs.ly/H0x_Zs-0

28/08/2026

In this short video, Dr. Gulnaz Zhumagualieva, Head of the Laboratory at Sayram Central District Hospital, shares her experience after nearly six years of using the semi-automated hemostasis analyzer Yumizen G400 she introduced, and explains how evolving requirements are shaping future automation plans.
👉Discover the Yumizen hemostasis solutions here: https://eu1.hubs.ly/H0xV7_30

25/08/2026

As antibiotic-resistant infections continue to increase worldwide, healthcare professionals face the challenge of preserving treatment effectiveness while ensuring optimal patient care.
Discover the drivers behind AMR and explore how evidence-based diagnostic approaches can support responsible antibiotic use.
🔗 Read the full whitepaper here: https://eu1.hubs.ly/H0xLQ0z0

20/08/2026

How does the Yumizen H550 support routine hematology testing?

In this 1-minute video, Ms Paola Michel González Hernández, Head of the Hematology Department at a laboratory in Durango, Mexico, shares her experience using the Yumizen H550 in daily practice.

What you'll learn
▪️The benefits observed in day-to-day hematology operations
▪️Why the analyzer supports efficient blood cell analysis and clinical decision-making

▶️ Watch the 1-minute laboratory testimonial
Hear directly from a laboratory professional about their experience with the Yumizen H550 and how it supports their daily work.

19/08/2026

✅ Quiz Answer: B
The extensive platelet clumping suggests that the low EDTA platelet count may be falsely reduced due to pseudothrombocytopenia.
Repeating the test using sodium citrate can help prevent EDTA-dependent aggregation and provide a more reliable result.
The citrate blood smear should also be checked to confirm that the clumping has resolved, and the result should be reported according to the laboratory’s validated procedure.

Dig deeper into the blood and blood disorders in our hematology newsletter, which focuses on blood morphology bringing you case studies & slide reviews, hemostasis, technologies, clinical advancements, and quizzes: https://www.horiba.com/int/healthcare/heme-insights/heme-insights-8?utm_source=facebook&utm_medium=share&utm_campaign=hmfr-healthcare-hemeinsights-2025&utm_term=8-quiz-answer&utm_content=19082026

It's quiz time with !

A patient’s EDTA sample gives a platelet count of 41 × 10⁹/L. The analyzer flags possible platelet clumps, and the blood smear shows aggregates. What is the most appropriate next step?

a) Report severe thrombocytopenia immediately.
b) Request a correctly collected citrate sample and analyze it promptly.
c) Issue a normal platelet result based on the smear estimate.
d) Ignore the clumps and repeat the EDTA count the next day.

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://eu1.hubs.ly/H0xlZKZ0

18/08/2026

🔬 New Chase the Case #59: Chronic Lymphocytic Leukemia (CLL)

In this month's Chase the Case, discover a clinical case of Chronic Lymphocytic Leukemia (CLL) and review the analyzer patterns, blood smear findings, and key observations that contributed to the diagnosis.

✅View the case on the website: https://eu1.hubs.ly/H0xHT7Y0
✅Subscribe: https://eu1.hubs.ly/H0xHTjh0

11/08/2026

It's quiz time with !

A patient’s EDTA sample gives a platelet count of 41 × 10⁹/L. The analyzer flags possible platelet clumps, and the blood smear shows aggregates. What is the most appropriate next step?

a) Report severe thrombocytopenia immediately.
b) Request a correctly collected citrate sample and analyze it promptly.
c) Issue a normal platelet result based on the smear estimate.
d) Ignore the clumps and repeat the EDTA count the next day.

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://eu1.hubs.ly/H0xlZKZ0